Canada’s first homegrown COVID-19 vaccine has shown high efficacy against infection during Phase 3 clinical trials, the drugmakers behind the plant-based shot reported Tuesday, fuelling hopes it could soon get a stamp of approval for use.
COVID-19 vaccine from Canada’s Medicago reports 75 per cent efficacy in Phase 3 trial
